ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

RSLS ReShape Lifesciences Inc

0.2011
-0.0101 (-4.78%)
27 7월(7) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
ReShape Lifesciences Inc RSLS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.0101 -4.78% 0.2011 08:22:34
개장가 저가 고가 종가 전일 종가
0.2152 0.20 0.2152 0.2016 0.2112
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
10/07/202401:13GLOBEVyome to go public and trade on the Nasdaq Capital Market..
09/07/202422:22EDGAR2Form 425 - Prospectuses and communications, business..
09/07/202422:21EDGAR2Form 8-K - Current report
09/07/202421:31GLOBEReShape Lifesciences® Enters Into Merger Agreement With..
21/05/202406:14EDGAR2Form 8-K - Current report
16/05/202405:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/05/202405:05GLOBEReShape Lifesciences® Reports First Quarter Ended March 31,..
14/05/202421:31GLOBEReShape Lifesciences® to Announce Financial Results for the..
02/04/202405:05GLOBEReShape Lifesciences® Reports Year Ended December 31, 2023..
28/03/202421:31GLOBEReShape Lifesciences® Receives Notice of Allowance for..
04/03/202422:31GLOBEReShape Lifesciences® Provides Update on 2024 Cost Reduction..
27/02/202406:19EDGAR2Form 8-K - Current report
22/02/202422:31GLOBEReShape Lifesciences® Announces First Surgeries Utilizing..
24/01/202422:31GLOBEReShape Lifesciences® Conducts Bariatric Fellows Training..
19/01/202406:38EDGAR2Form 8-K - Current report
17/01/202408:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/01/202406:14EDGAR2Form PRE 14A - Other preliminary proxy statements
20/12/202322:31GLOBEReShape Lifesciences® Engages Maxim Group LLC To Identify..
13/12/202306:05GLOBEReShape Lifesciences® Receives FDA PMA Supplement Approval..
30/11/202306:05EDGAR2Form 8-K - Current report
21/11/202322:06GLOBEReShape Lifesciences® Enters into Warrant Exercise..
09/11/202306:05GLOBEReShape Lifesciences® Reports Third Quarter Ended September..
06/11/202322:31GLOBEReShape Lifesciences® to Announce Financial Results for the..
14/10/202305:42EDGAR2Form 8-K - Current report
06/10/202305:05EDGAR2Form 8-K - Current report
03/10/202322:23EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
30/09/202301:30GLOBEReShape Lifesciences® Announces Pricing of $3.0 Million..
28/09/202306:30EDGAR2Form S-1/A - General form for registration of securities..
23/09/202305:02EDGAR2Form 8-K - Current report
22/09/202321:31GLOBEReShape Lifesciences® Announces Participation in the LD..
21/09/202321:31GLOBEReShape Lifesciences® Signs Exclusive License Agreement With..
19/09/202321:31GLOBEReShape Lifesciences® Significantly Strengthens Patent..
14/09/202321:31GLOBEReShape Lifesciences® Receives NIH SBIR Grant to Further..
26/08/202305:41EDGAR2Form S-1 - General form for registration of securities under..
08/08/202306:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202305:54EDGAR2Form 8-K - Current report
08/08/202305:05GLOBEReShape Lifesciences® Reports Second Quarter Ended June 30,..
04/08/202305:05GLOBEReShape Lifesciences® to Announce Financial Results for the..

최근 히스토리

Delayed Upgrade Clock